Robeco Institutional Asset Management B.V. Trims Position in GE HealthCare Technologies Inc. $GEHC

Robeco Institutional Asset Management B.V. trimmed its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 70.9% in the second quarter, according to its most recent disclosure with the SEC. The fund owned 30,067 shares of the company's stock after selling 73,141 shares during the period. Robeco Institutional Asset Management B.V.'s holdings in GE HealthCare Technologies were worth $2,227,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also made changes to their positions in GEHC. NBC Securities Inc. purchased a new stake in shares of GE HealthCare Technologies in the first quarter valued at about $43,000. Wedmont Private Capital raised its holdings in shares of GE HealthCare Technologies by 7.0% in the first quarter. Wedmont Private Capital now owns 6,068 shares of the company's stock valued at $490,000 after buying an additional 395 shares during the last quarter. UMB Bank n.a. raised its holdings in shares of GE HealthCare Technologies by 17.1% in the first quarter. UMB Bank n.a. now owns 2,180 shares of the company's stock valued at $176,000 after buying an additional 318 shares during the last quarter. Miracle Mile Advisors LLC raised its holdings in shares of GE HealthCare Technologies by 50.2% in the first quarter. Miracle Mile Advisors LLC now owns 4,621 shares of the company's stock valued at $373,000 after buying an additional 1,545 shares during the last quarter. Finally, Park Avenue Securities LLC raised its holdings in shares of GE HealthCare Technologies by 32.3% in the first quarter. Park Avenue Securities LLC now owns 5,887 shares of the company's stock valued at $475,000 after buying an additional 1,437 shares during the last quarter. 82.06% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of brokerages have recently commented on GEHC. Zacks Research cut shares of GE HealthCare Technologies from a "strong-buy" rating to a "hold" rating in a report on Monday, September 29th. Citigroup lowered shares of GE HealthCare Technologies from a "buy" rating to a "neutral" rating and dropped their price target for the stock from $93.00 to $83.00 in a research note on Tuesday. Morgan Stanley set a $74.00 price target on shares of GE HealthCare Technologies in a research note on Thursday, September 18th. Weiss Ratings reiterated a "hold (c)" rating on shares of GE HealthCare Technologies in a research note on Saturday, September 27th. Finally, BTIG Research reiterated a "buy" rating on shares of GE HealthCare Technologies in a research note on Monday, July 14th. Six investment analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and an average price target of $85.78.

GE HealthCare Technologies Trading Down 2.5%

Shares of GEHC opened at $74.49 on Wednesday. The company has a current ratio of 1.16, a quick ratio of 0.93 and a debt-to-equity ratio of 0.85. The firm's 50-day moving average is $74.15 and its two-hundred day moving average is $72.46. GE HealthCare Technologies Inc. has a twelve month low of $57.65 and a twelve month high of $94.80. The firm has a market capitalization of $34.01 billion, a P/E ratio of 15.26, a PEG ratio of 2.92 and a beta of 1.13.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last issued its earnings results on Wednesday, July 30th. The company reported $1.06 earnings per share for the quarter, topping the consensus estimate of $0.91 by $0.15. GE HealthCare Technologies had a net margin of 11.22% and a return on equity of 23.93%. The company had revenue of $5 billion for the quarter, compared to analyst estimates of $4.96 billion. During the same period in the prior year, the business posted $1.00 earnings per share. The firm's revenue for the quarter was up 3.5% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2025 guidance at 4.430-4.630 EPS. On average, research analysts predict that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, November 14th. Stockholders of record on Friday, October 24th will be given a $0.035 dividend. The ex-dividend date is Friday, October 24th. This represents a $0.14 annualized dividend and a dividend yield of 0.2%. GE HealthCare Technologies's dividend payout ratio is currently 2.87%.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.

Want to see what other hedge funds are holding GEHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.